• Study of Volrustomig for Patients with Advanced Solid Tumors with Mature Tertiary Lymphoid Structures

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Croatia Czechia Poland Romania Spain

  • Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Systemic Lupus Erythematosus

    Not recruiting

    2 1
    Investigated Drugs:
    Hungary Poland Romania Spain

  • Study on the Effectiveness and Safety of RO7434656 for Patients with Primary IgA Nephropathy at High Risk of Progression

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Greece Italy Poland +1

  • Study of Futibatinib for Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Poland Portugal Spain

  • Study on Alteplase for Vision Recovery in Patients with Acute Central Retinal Artery Occlusion

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium Bulgaria Croatia France Germany Greece +5

  • Study on LSTA1 and Temozolomide for Patients with Newly Diagnosed Glioblastoma Multiforme

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Estonia Latvia Lithuania

  • Study on GnRH Agonists for Ovulation and Luteal Support in IVF Patients: Comparing GnRH Agonist with hCG and Progesterone

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    France

  • Study of HST-1011 Alone and with Cemiplimab for Patients with Advanced Solid Tumors Not Responding to Standard Treatments

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

powered by